KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Restructuring Costs (2018 - 2025)

Arbutus Biopharma's Restructuring Costs history spans 6 years, with the latest figure at $98000.0 for Q3 2025.

  • For Q3 2025, Restructuring Costs fell 97.3% year-over-year to $98000.0; the TTM value through Sep 2025 reached $25.0 million, up 589.46%, while the annual FY2024 figure was $3.7 million, N/A changed from the prior year.
  • Restructuring Costs for Q3 2025 was $98000.0 at Arbutus Biopharma, down from $12.4 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $12.4 million in Q1 2025 and bottomed at $95000.0 in Q4 2024.